seed
Stage
1
Investors
About
WhiteLab Genomics develops an AI-driven computational platform (ALFRED) to design and optimize genomic medicines, including AAV, lentiviral and non-viral vectors, RNA payloads and delivery systems. They provide in silico design and wet-lab validation services to accelerate and de-risk gene and RNA therapy development for biotech and pharma partners.
Explore WhiteLab Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.